ADAMTS13 and thrombotic thrombocytopenic purpura: Whilst the literature often classifies TTP patients as being in “remission”, we are beginning to observe an increasing number of reports detecting subclinical biomarkers for patients whose ADAMTS13 falls below the threshold of 70% and, in some cases, <10% in the presence of normal full blood count indices.